(MedPage Today) — The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.
Gepotidacin is the first in a new class of antibiotics…
Physicians want N.L. to hit pause on a mandatory, province-wide electronic health information system
Doctors in Newfoundland and Labrador says quick implementation of a province-wide electronic health information system threatens to harm patients and...






